120 related articles for article (PubMed ID: 19656663)
1. Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors.
Tanibuchi Y; Fujita Y; Kohno M; Ishima T; Takatsu Y; Iyo M; Hashimoto K
Eur Neuropsychopharmacol; 2009 Dec; 19(12):861-7. PubMed ID: 19656663
[TBL] [Abstract][Full Text] [Related]
2. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
[TBL] [Abstract][Full Text] [Related]
3. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.
Hashimoto K; Fujita Y; Ishima T; Chaki S; Iyo M
Eur Neuropsychopharmacol; 2008 Jun; 18(6):414-21. PubMed ID: 17804206
[TBL] [Abstract][Full Text] [Related]
4. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.
Kunitachi S; Fujita Y; Ishima T; Kohno M; Horio M; Tanibuchi Y; Shirayama Y; Iyo M; Hashimoto K
Brain Res; 2009 Jul; 1279():189-96. PubMed ID: 19433073
[TBL] [Abstract][Full Text] [Related]
5. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol.
Hashimoto K; Fujita Y; Shimizu E; Iyo M
Eur J Pharmacol; 2005 Sep; 519(1-2):114-7. PubMed ID: 16099452
[TBL] [Abstract][Full Text] [Related]
6. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline.
Fujita Y; Ishima T; Kunitachi S; Hagiwara H; Zhang L; Iyo M; Hashimoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):336-9. PubMed ID: 17884273
[TBL] [Abstract][Full Text] [Related]
7. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
Bakshi VP; Geyer MA
J Pharmacol Exp Ther; 1997 Nov; 283(2):666-74. PubMed ID: 9353384
[TBL] [Abstract][Full Text] [Related]
8. The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL/Bax ratio in the posterior cingulate cortex in rats.
He J; Xu H; Yang Y; Rajakumar D; Li X; Li XM
Behav Brain Res; 2006 Apr; 168(2):236-42. PubMed ID: 16360889
[TBL] [Abstract][Full Text] [Related]
9. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors.
Hashimoto K; Fujita Y; Ishima T; Hagiwara H; Iyo M
Eur J Pharmacol; 2006 Dec; 553(1-3):191-5. PubMed ID: 17094961
[TBL] [Abstract][Full Text] [Related]
10. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
Abdul-Monim Z; Reynolds GP; Neill JC
Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
Horio M; Fujita Y; Hashimoto K
Fundam Clin Pharmacol; 2013 Oct; 27(5):483-8. PubMed ID: 22594375
[TBL] [Abstract][Full Text] [Related]
12. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
13. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.
Hashimoto K; Ishima T; Fujita Y; Matsuo M; Kobashi T; Takahagi M; Tsukada H; Iyo M
Biol Psychiatry; 2008 Jan; 63(1):92-7. PubMed ID: 17601496
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.
Grayson B; Idris NF; Neill JC
Behav Brain Res; 2007 Nov; 184(1):31-8. PubMed ID: 17675172
[TBL] [Abstract][Full Text] [Related]
15. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.
Hashimoto K; Fujita Y; Iyo M
Neuropsychopharmacology; 2007 Mar; 32(3):514-21. PubMed ID: 16495935
[TBL] [Abstract][Full Text] [Related]
16. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
Beraki S; Kuzmin A; Tai F; Ogren SO
Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
18. Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: a role for serotonin 5-HT1A receptors.
Yoshimi N; Fujita Y; Ohgi Y; Futamura T; Kikuchi T; Hashimoto K
Pharmacol Biochem Behav; 2014 Sep; 124():245-9. PubMed ID: 24955861
[TBL] [Abstract][Full Text] [Related]
19. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
McLean SL; Idris NF; Woolley ML; Neill JC
Eur Neuropsychopharmacol; 2009 Jun; 19(6):440-50. PubMed ID: 19268547
[TBL] [Abstract][Full Text] [Related]
20. "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats.
Martinez ZA; Platten A; Pollack E; Shoemaker J; Ro H; Pitcher L; Geyer MA; Swerdlow NR
Psychopharmacology (Berl); 2002 Apr; 161(1):38-46. PubMed ID: 11967629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
